Anti-inflammatory and anti-nociceptive activity of risedronate in experimental pain models in rats and mice

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 7, 2006, Pages 601-606

  Carvalho, Aline P ^a   Bezerra, Mirna M ^a   Girão, Virgínia C C ^a   Cunha, Fernando Q ^b   Rocha, Francisco A C ^a,c  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Arthritis; Bisphosphonates; Leukotriene B4; Tumor necrosis factor; Zymosan

Indexed keywords

ACETIC ACID; LEUKOTRIENE B4; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; RISEDRONIC ACID; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTHRITIS; ARTICLE; CELL INFILTRATION; CELL TRANSFER; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; INFLAMMATORY CELL; KNEE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; RAT; STIMULUS RESPONSE; WRITHING TEST;

ACETIC ACID; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETIDRONIC ACID; INFLAMMATION; LEUKOTRIENE B4; MALE; MICE; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 33745171751     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04413.x     Document Type: Article

References (29)

1. Fleisch H. Bisphosphonates: A new class of drugs in disease of bone and calcium metabolism. Recent Results Cancer Res. 1989 116 : 1 28.
2. Langston AL Ralston SH. Management of Paget's disease of bone. Rheumatology 2004 43 : 955 9.
3. Walker K Medhurst SJ Kidd BL et al. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain 2002 100 : 219 29.
4. Goicoechea C Porras E Alfaro MJ Martin MI. Alendronate induces antinociception in mice, not related with its effects in bone. Jpn. J. Pharmacol. 1999 79 : 433 7.
5. Umland EM Boyce EG. Risedronate: A new oral bisphosphonate. Clin. Ther. 2001 23 : 1409 21.
6. Cranney A Waldegger L Zytaruk N et al. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database Syst. Rev. 2003 4 : CD004523.
7. Collier HOJ Dinneen LC Chistine A Johnson A Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother. 1968 32 : 295 310.
8. Rocha FA Aragão Jr AG Oliveira RC Pompeu MM Vale MR Ribeiro RA. Periarthritis promotes gait disturbance in zymosan-induced arthritis in rats. Inflamm. Res. 1999 48 : 485 90.
9. Ribeiro RA Vale ML Thomazzi SM Cunha FQ Ferreira SH. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur. J. Pharmacol. 2000 387 : 111 18.
10. Tonussi CR Ferreira SH. Rat-knee joint incapacitation test: An objective screen for central and peripheral analgesics. Pain 1992 48 : 421 7.
11. Adami S. Bisphosphonates in prostate carcinoma. Cancer 1997 80 : 1674 9.
12. Body JJ Lortholary A Romieu G Vigneron AM Ford J. A dose-finding study of zoledronate in hypercalcemic cancer patients. J. Bone Miner. Res. 1999 14 : 1557 61.
13. Berenson JR Rosen LS Howell A et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer 2001 91 : 1191 200.
14. Bonabello A Galmozzi MR Bruzzese T Zara GP. Analgesic effect of bisphosphonates in mice. Pain 2001 91 : 269 75.
15. Nakamura M Ando T Abe M Kumagai K Endo Y. Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice. Br. J. Pharmacol. 1996 119 : 205 12.
16. Matsuo A Shuto T Hirata G et al. Antiinflammatory and chondroprotective effects of the aminobisphosphonate incadronate (YM175) in adjuvant induced arthritis. J. Rheumatol. 2003 30 : 1280 90.
17. Otterness IG Milici AJ Bliven ML. Some factors affecting inhibition and restoration of mobility after induction of an acute arthritis in the hamster. Agents Actions 1993 40 : 224 7.
18. Cunha FQ Poole S Lorenzetti BB Ferreira SH. The pivotal role of tumor necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 1992 107 : 660 4.
19. Moreira AL Sampaio EP Zmuidzinas A Frindt P Smith KA Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 1993 177 : 1675 80.
20. Breedveld FC Kalden JR. Appropriate and effective management of rheumatoid arthritis. Ann. Rheum. Dis. 2004 63 : 627 33.
21. Liu Y Cortinovis D Stone MA. Recent advances in the treatment of the spondyloarthropathies. Curr. Opin. Rheumatol. 2001 16 : 357 65.
22. Richards PJ Williams BD Williams AS. Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate. Rheumatology 2001 40 : 978 87.
23. Ceponis A Waris E Monkkonen J et al. Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbits. Arthritis Rheum. 2001 44 : 1908 16.
24. Dicuonzo G Vincenzi B Santini D et al. Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J. Interferon Cytokine Res. 2003 23 : 649 54.
25. Ford-Huctinson AW. Leukotriene B4 inflammation. Crit. Rev. Immunol. 1990 10 : 1 11.
26. Levine JD Lau W Kwiat G Goetzl EJ. Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 1984 225 : 743 5.
27. Cunha JM Sachs D Canetti CA Poole S Ferreira SH Cunha FQ. The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats. Br. J. Pharmacol. 2003 139 : 1135 45.
28. Cocco R Tofi C Fioravanti A et al. Effects of clodronate on synovial fluid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis. Boll. Soc. Ital. Biol. Sper. 1999 75 : 71 6.
29. Luurila S Kautiainen S Ylitalo P Ylitalo R. Pharmacokinetics of bisphosphonates in rabbits. Pharmacol. Toxicol. 1999 84 : 24 8.